Source: Neuropharmacology. Unidade: FMRP
Subjects: NEUROFARMACOLOGIA, APOPTOSE, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, v. 140, p. 201-208, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.08.009. Acesso em: 09 maio 2024.APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Oliveira, S. A. de, Guimarães, F. S., & Oliveira, A. L. R. de. (2018). Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, 140, 201-208. doi:10.1016/j.neuropharm.2018.08.009NLM
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009